Firstly, FGF21 reduces insulin resistance by stimulating insulin secretion via the PI3K/Akt signaling pathway, enhancing postprandial insulin sensitivity (Rusu et al., 2017; Tan et al., 2023). The gene discussed is FGF21; the disease is Insulin resistance.